Evidence map›Paper›PMID 30360548›Full record

ArticleBiomolecules2018

In Silico Studies on Compounds Derived from

Marco A Loza-Mejía, Juan Rodrigo Salazar, Juan Francisco Sánchez-Tejeda

Abstract read
In one paragraph

Article in Biomolecules, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Hepatoprotective Properties ofFood science & nutrition · 2025
    Article
  5. Article
  6. Pioneering study of Egyptian Neem and Jojoba extracts with molecular docking combat hospital multidrug resistant bacteria.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  7. Article
  8. Frontiers in plant science · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marco A Loza-MejíaBenjamín Franklin 45, Cuauhtémoc, Mexico City 06140, Mexico. marcoantonio.loza@ulsa.mx.ORCID 0000-0002-8449-0806
Juan Rodrigo SalazarBenjamín Franklin 45, Cuauhtémoc, Mexico City 06140, Mexico. juan.salazar@ulsa.mx.ORCID 0000-0002-8839-5849
Juan Francisco Sánchez-TejedaBenjamín Franklin 45, Cuauhtémoc, Mexico City 06140, Mexico. juansanchez@lasallistas.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An increasing occurrence of resistance in insect pests and high mammal toxicity exhibited by common pesticides increase the need for new alternative molecules. Among these alternatives, bioinsecticides are considered to be environmentally friendly and safer than synthetic insecticides. Particularly, plant extracts have shown great potential in laboratory conditions. However, the lack of studies that confirm their mechanisms of action diminishes their potential applications on a large scale. Previously, we have reported the insect growth regulator and insecticidal activities of secondary metabolites isolated from plants of the

Indexed as

Computer SimulationAcetylcholinesteraseAnimalsCalceolariaceaeDrosophila melanogasterEnzyme InhibitorsGlucosidesGlycosidesHumansMolecular Docking SimulationPesticidesPhenolsPolyphenolsReceptors, SteroidAcetylcholinesteraseacteosideecdysone receptorEnzyme InhibitorsGlucosidesGlycosidesPesticidesPhenolsPolyphenolsReceptors, SteroidbioinsecticidesCalceolariamolecular dockingmultitargetphenylethanoid glycosidesstructure–activity relationship

Identifiers

PMID30360548
PMCPMC6322355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.